HIF1A and central nervous system cancer: Based on previous investigations into the effects of silencing HIF-1α on radiation survival outcomes in U87 and U251 glioma cells [50], [51], we know that enhanced radiotherapeutic efficacy following downregulation of HIF-1 can result from delayed cell cycle progression and increased incidence of mitotic catastrophe and apoptosis.